EW
Edwards Lifesciences Corp
NYSE · Healthcare · Medical - Devices · US
$87.22
+0.72%Forward multiples
Based on analyst estimates
- P/E forward
- 26.81x
- P/E 2026E
- 28.97x
- P/E 2027E
- 25.64x
- P/E 2028E
- 22.83x
- P/S forward
- 6.94x
Trailing multiples
Trailing twelve months
- P/E TTM
- 50.13x
- PEG TTM
- 0.57x
- Price / book
- 4.73x
- Price / sales
- 7.72x
- Price / cash flow
- 29.22x
Enterprise value
- Enterprise value
- $46.8B
- EV / sales
- 7.19x
- EV / EBITDA
- 29.59x
- EV / EBIT
- 25.60x
- Market cap
- $50.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026